MNMunazza Mbbs Nazir

Munazza Mbbs Nazir

*This is an algorithmically generated author record based on publicly available information.

Munazza Mbbs Nazir has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correlation between allergic rhinitis or hay fever and lung cancer: A systematic review and meta-analysis

    by Qudsia Umaira Mbbs Khan, Muneeb Ur Mbbs Rehman, Mohammad Ali Arshad Mbbs Abbasi, Rubina Rafique Mbbs Shiekh, Munazza Mbbs Nazir, Sohail Khan Mbbs Raja, Amna Mbbs Akbar, Sabahat Bds Tasneem, Sarosh Khan Mbbs Jadoon, Sarosh Bs Alvi

    Background: The association between allergies and cancer is contradictory, whereas some forms of cancer have inverse associations with allergies. Allergic rhinitis (AR) is the most prevalent form of allergy, and lung cancer is one of the most prevalent forms of cancer with the highest mortality rate. Recent studies have reported a positive association between asthma and lung cancer; however, this association is inconclusive. Furthermore, AR is positively associated with asthma; therefore, our research question was to explore whether there is any correlation between AR and lung cancer epidemiologically. Methods: After a rigorous search of PubMed, Google Scholar, and ScienceDirect, 7 eligible articles were included in this systematic review and meta-analysis, including 4724 cases and 9059 controls, 5 from the USA, and one each from Canada and Germany. Results: Pooled analysis (OR, 0.55; 95% CI: 0.45–0.68; P value < .00001) showed a strong inverse relationship between AR and lung cancer. Conclusion: The current meta-analysis suggests an inverse relationship between AR and lung cancer; however, new epidemiological studies are required to observe the current scenario more comprehensively.


  • Open Access

    A COMPREHENSIVE INVESTIGATION INTO THE INFLUENCE OF REMDESIVIR ON MORTALITY AND MORBIDITY AMONG INDIVIDUALS AFFLICTED WITH COVID-19: RETROSPECTIVE COHORT STUDY

    by Sohail Khan Raja, Hamdah Bashir Mughal, Rubina Rafique Shiekh, Munazza Nazir, Bushra Bashir, Easha Tur Razia, Amna Akbar, Sabahat Tasneem, Sarosh Khan Jadoon, Saddam Hussain

    Background: Remdesivir’s distinct method of action is a promising strategy for battling viral illnesses. It assists in lowering the viral load and reducing the severity and length of infection by interfering with the replication mechanism of the virus. Methodology: Retrospective cohort study was conducted at a tertiary care hospital in AJK, Pakistan. The data was collected from hospital records and the analysis was performed to find the effectiveness of Remdesivir. Results: There were 62.7% males and 37.3% females and the most common symptoms were fever, cough and shortness of breath. Remdesivir was initiated early in 126 patients. The mean number of doses is 2.0 and Remdesivir affects the recovery (p<0.05). Conclusion: Remdesivir can be administered in COVID-19 patients but the results from past are mix. Remdesivir has good therapeutic efficacy.